Skip to content

Clinical profile (details related to disease, treatment and response)of children who received High Frequency mode of ventilation for respiratory failure due to inadequate oxygen levels in post-OSCAR and OSCILLATE trials era

Clinical profile of children who received high frequency ventilation for hypoxemic respiratory failure in post- OSCAR and OSCILLATE trials era

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/12/029648
Enrollment
20
Registered
2020-12-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J962- Acute and chronic respiratory failure

Interventions

None listed

Sponsors

DR ANUPAMA YERRA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All children aged between 1 month and 18 years with hypoxemic respiratory failure requiring high frequency oscillation ventilation

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
To compare the clinical profile of children with hypoxemic respiratory failure who survived on high frequency ventilation with children with hypoxemic respiratory failure who died on high frequency ventilationTimepoint: 1 year

Secondary

MeasureTime frame
association of cumulative fluid balance, renal angina index on outcome of children on HFOVTimepoint: 1 year;association of HFOV settings on outcome parameters like ventilator days, air leaks, hemodynamic instability, PICU stay, mortalityTimepoint: 1 year;association of proning maneuvers on the outcome of children on HFOVTimepoint: 1 year;possible outcome predictors for children with hypoxemic respiratory failure on HFOVTimepoint: 1 year

Countries

India

Contacts

Public ContactDr G ADITYA KIRAN

RAINBOW CHILDRENS HOSPITAL

puttaanu@gmail.com8008740697

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026